Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).

Gerd Fastner; Roland Reitsamer; Christoph Gaisberger; Wolfgang Hitzl; Bartosz Urbański; Dawid Murawa; Christiane Matuschek; Wilfried Budach; Antonella Ciabattoni; Juliann Reiland; Marie Molnar; Cristiana Vidali; Claudia Schumacher; Felix Sedlmayer; On Behalf Of The Hiob Trialist Group; Falk Röder

doi:10.3390/cancers14061396

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).

Gerd Fastner^* (Erstautor/-in)
, Roland Reitsamer (Co-Autor/-in)
, Christoph Gaisberger (Co-Autor/-in)
, Wolfgang Hitzl (Co-Autor/-in)
, Bartosz Urbański
, Dawid Murawa
, Christiane Matuschek
, Wilfried Budach
, Antonella Ciabattoni
, Juliann Reiland
, Marie Molnar
, Cristiana Vidali
, Claudia Schumacher
, Felix Sedlmayer (Letztautor/-in)
, On Behalf Of The Hiob Trialist Group
, Falk Röder (Study group member)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

5 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Cancers
Jahrgang	14
Ausgabenummer	6
DOIs	https://doi.org/10.3390/cancers14061396
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/cancers14061396

Dieses zitieren

Fastner, G., Reitsamer, R., Gaisberger, C., Hitzl, W., Urbański, B., Murawa, D., Matuschek, C., Budach, W., Ciabattoni, A., Reiland, J., Molnar, M., Vidali, C., Schumacher, C., Sedlmayer, F., On Behalf Of The Hiob Trialist Group, & Röder, F. (2022). Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459). Cancers, 14(6). https://doi.org/10.3390/cancers14061396

@article{e4dbe5f0357a4d2e933de85e51df0278,

title = "Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).",

keywords = "EXTERNAL-BEAM RADIOTHERAPY, INTRAOPERATIVE RADIOTHERAPY, CONSERVING SURGERY, UK STANDARDIZATION, RADIATION-THERAPY, CONSENSUS STATEMENT, RECURRENCE RATES, FOLLOW-UP, X-RAYS, TOXICITY",

author = "Gerd Fastner and Roland Reitsamer and Christoph Gaisberger and Wolfgang Hitzl and Bartosz Urba{\'n}ski and Dawid Murawa and Christiane Matuschek and Wilfried Budach and Antonella Ciabattoni and Juliann Reiland and Marie Molnar and Cristiana Vidali and Claudia Schumacher and Felix Sedlmayer and \{On Behalf Of The Hiob Trialist Group\} and Falk R{\"o}der",

note = "Fastner, Gaisberger, Sedlmayer: Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Reitsamer: Department of Gynecology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Hitzl: Research Office—Biostatistics, Paracelsus Medical University, 5020 Salzburg, Austria. Hitzl: Department of Ophthalmology and Optometry, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Hitzl: Research Program for Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University, 5020 Salzburg, Austria. ",

year = "2022",

doi = "10.3390/cancers14061396",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "6",

}

Fastner, G , Reitsamer, R , Gaisberger, C , Hitzl, W, Urbański, B, Murawa, D, Matuschek, C, Budach, W, Ciabattoni, A, Reiland, J, Molnar, M, Vidali, C, Schumacher, C, Sedlmayer, F, On Behalf Of The Hiob Trialist Group, & Röder, F 2022, 'Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).', Cancers, Jg. 14, Nr. 6. https://doi.org/10.3390/cancers14061396

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459). / Fastner, Gerd (Erstautor/-in); Reitsamer, Roland (Co-Autor/-in); Gaisberger, Christoph (Co-Autor/-in) et al.
in: Cancers, Jahrgang 14, Nr. 6, 2022.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459).

AU - Fastner, Gerd

AU - Reitsamer, Roland

AU - Gaisberger, Christoph

AU - Hitzl, Wolfgang

AU - Urbański, Bartosz

AU - Murawa, Dawid

AU - Matuschek, Christiane

AU - Budach, Wilfried

AU - Ciabattoni, Antonella

AU - Reiland, Juliann

AU - Molnar, Marie

AU - Vidali, Cristiana

AU - Schumacher, Claudia

AU - Sedlmayer, Felix

AU - On Behalf Of The Hiob Trialist Group, null

A2 - Röder, Falk

N1 - Fastner, Gaisberger, Sedlmayer: Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Reitsamer: Department of Gynecology, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Hitzl: Research Office—Biostatistics, Paracelsus Medical University, 5020 Salzburg, Austria. Hitzl: Department of Ophthalmology and Optometry, Paracelsus Medical University, University Hospital Salzburg, Landeskrankenhaus, 5020 Salzburg, Austria. Hitzl: Research Program for Experimental Ophthalmology and Glaucoma Research, Paracelsus Medical University, 5020 Salzburg, Austria.

PY - 2022

Y1 - 2022

KW - EXTERNAL-BEAM RADIOTHERAPY

KW - INTRAOPERATIVE RADIOTHERAPY

KW - CONSERVING SURGERY

KW - UK STANDARDIZATION

KW - RADIATION-THERAPY

KW - CONSENSUS STATEMENT

KW - RECURRENCE RATES

KW - FOLLOW-UP

KW - X-RAYS

KW - TOXICITY

U2 - 10.3390/cancers14061396

DO - 10.3390/cancers14061396

M3 - Original Article

C2 - 35326548

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 6

ER -